What Researchers Did
Researchers investigated the effects of hyperbaric oxygen therapy (HBOT) on glycemic control, atherosclerosis, and inflammatory markers in 28 patients with Wagner grade 2-4 diabetic foot ulcerations.
What They Found
After 30 sessions of hyperbaric oxygen therapy, all 28 patients showed statistically significant improvements in mean values for glycemic control, atherosclerosis markers, and inflammatory parameters. Beneficial effects were observed across fasting blood glucose, HbA1c, HOMA-IR, hs-CRP, uric acid, MPV, and lipid profiles.
What This Means for Canadian Patients
For Canadian patients with diabetic foot ulcerations, hyperbaric oxygen therapy may offer an additional treatment option to improve glycemic control and reduce markers of atherosclerosis and inflammation. This could potentially lead to better overall health outcomes and reduced complications associated with diabetes.
Canadian Relevance
This study has no direct Canadian connection as it was not conducted in Canada nor involved Canadian participants or researchers.
Study Limitations
A key limitation is the small sample size of 28 patients, and further large-scale randomized studies are needed to confirm these systemic effects.